Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Blombery

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Pathology|May 3, 2013
An atypical presentation of persistent polyclonal B-lymphocytosis with symptomatic splenomegaly and response to rituximabPiers Blombery, Neil Came, Ellen Maxwell, et al.
Hematology/Oncology Clinics of North America|November 28, 2016
Transformed LymphomaMary Ann Anderson, Piers Blombery, John F Seymour
Pathology|April 20, 2026
MPL W515R hereditary thrombocytosis associated with a benign long-term clinical courseErin O'Reilly, Samuel Grigg, Paul Monagle, et al.
Journal of the National Cancer Institute|April 5, 2017
Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of LymphomaPiers Blombery, Henry M Prince, John F Seymour
Plastic and Reconstructive Surgery|March 1, 2019
Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell LymphomaPiers Blombery, Ella R Thompson, H Miles Prince
The New England Journal of Medicine|June 26, 2024
Response and Resistance to Menin Inhibitor in <i>UBTF</i>-Tandem Duplication AMLIng Soo Tiong, David S Ritchie, Piers Blombery
American Journal of Hematology|July 13, 2017
Marked leukemoid reaction in a patient with metastatic breast carcinomaYasmin Harvey, Shane Bleakley, Piers Blombery, et al.
Current Treatment Options in Oncology|May 30, 2023
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell LymphomaSimon Wu, Piers Blombery, David Westerman, et al.
Leukemia & Lymphoma|December 24, 2015
Copper deficiency mimicking myelodysplastic syndromeKirsty Rady, David Westerman, Piers Blombery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Erdheim-Chester disease harboring the BRAF V600E mutationPiers Blombery, Stephen Q Wong, Stephen Lade, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Pathology|May 3, 2013
An atypical presentation of persistent polyclonal B-lymphocytosis with symptomatic splenomegaly and response to rituximabPiers Blombery, Neil Came, Ellen Maxwell, et al.
Hematology/Oncology Clinics of North America|November 28, 2016
Transformed LymphomaMary Ann Anderson, Piers Blombery, John F Seymour
Pathology|April 20, 2026
MPL W515R hereditary thrombocytosis associated with a benign long-term clinical courseErin O'Reilly, Samuel Grigg, Paul Monagle, et al.
Journal of the National Cancer Institute|April 5, 2017
Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of LymphomaPiers Blombery, Henry M Prince, John F Seymour
Plastic and Reconstructive Surgery|March 1, 2019
Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell LymphomaPiers Blombery, Ella R Thompson, H Miles Prince
The New England Journal of Medicine|June 26, 2024
Response and Resistance to Menin Inhibitor in <i>UBTF</i>-Tandem Duplication AMLIng Soo Tiong, David S Ritchie, Piers Blombery
American Journal of Hematology|July 13, 2017
Marked leukemoid reaction in a patient with metastatic breast carcinomaYasmin Harvey, Shane Bleakley, Piers Blombery, et al.
Current Treatment Options in Oncology|May 30, 2023
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell LymphomaSimon Wu, Piers Blombery, David Westerman, et al.
Leukemia & Lymphoma|December 24, 2015
Copper deficiency mimicking myelodysplastic syndromeKirsty Rady, David Westerman, Piers Blombery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Erdheim-Chester disease harboring the BRAF V600E mutationPiers Blombery, Stephen Q Wong, Stephen Lade, et al.
Pageof 16